ulcerative colitis
The company is hoping to gain a local coverage determination from CMS this year as it solidifies data for its first assay and works on building out a larger menu.
ProciseDx Gets CE Mark for Point-of-Care Inflammatory Bowel Disease Test
The fecal calprotectin test, which runs on the company's ProciseDx immunoassay system, is designed to help in the diagnosis of Crohn's disease and ulcerative colitis.
Theradiag Kits for Biotherapy Monitoring Get CE Marks
The four kits are compatible with the i-Track automated analyzer for biotherapy monitoring, which received CE marking in late 2019.
PredictImmune Inks Multinational Commercialization Pact for IBD Test
The test is designed to analyze the expression of 17 genes in order to differentiate mild and aggressive forms of Crohn's disease and ulcerative colitis.
Scipher Medicine Closes Series B Funding Round
The company has raised $30 million to date to fund development and commercialization of its molecular diagnostic test to predict response to anti-TNF therapies.